SMid Biotech Analyst Rama holds a conference call with CMO Malik and CCO Perry on June 17 at 11 am hosted by JPMorgan.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GTHX:
- G1 Therapeutics announces inducement grants under Nasdaq listing rule
- G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- G1 Therapeutics’ trilaciclib combiation improves breast cancer overall survival
- Meaningful Improvement in Overall Survival (OS) and Tolerability Observed in Patients Receiving Trilaciclib in Combination with a TROP2 Antibody-Drug Conjugate (ADC)
- G1 Therapeutics announces upcoming presentation on trilaciclib at ASOCO